Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.11
+0.04
(+4.23%)
After-Hours: 19:57
Opus Genetics Total Liabilities (Quarterly): 4.198M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.198M |
| March 31, 2024 | 5.787M |
| December 31, 2023 | 4.042M |
| September 30, 2023 | 3.909M |
| June 30, 2023 | 5.761M |
| March 31, 2023 | 4.154M |
| December 31, 2022 | 2.753M |
| September 30, 2022 | 2.691M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.304M |
| March 31, 2022 | 3.213M |
| December 31, 2021 | 3.855M |
| September 30, 2021 | 2.638M |
| June 30, 2021 | 2.699M |
| March 31, 2021 | 2.31M |
| December 31, 2020 | 31.15M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.31M
Minimum
Mar 2021
31.15M
Maximum
Dec 2020
5.498M
Average
3.855M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Baxter International Inc | 18.60B |
| Syros Pharmaceuticals Inc | 96.12M |
| Elanco Animal Health Inc | 6.76B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.83M |
| Shareholders Equity (Quarterly) | 40.64M |
| Current Ratio | 10.68 |